Skip to main content
VWAV
NASDAQ Technology

VisionWave Posts $45.8M Loss, Cites Funding Support to Ease Going Concern, and Secures $15M Convertible Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Aerospace & Defense Stocks · Industrial
Sentiment info
Negative
Importance info
8
Price
$1.24
Mkt Cap
$34.202M
52W Low
$1.03
52W High
$15.8
52W Position info
20% above low
Off High info
92% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

VWAV sits 20% above its 52-week low of $1.03.

Summary

VisionWave's quarterly report reveals deep losses and a tight cash position, but management says a related-party funding commitment removes going concern doubt. A new $15M convertible financing and note conversion add dilution.


Key Events · Earnings and Guidance · VWAV

  • Net Loss of $45.8M

    For the nine months ended June 30, 2026, VisionWave reported a net loss of $45.8M, compared to $388K in the prior year period, driven by $35.9M in operating expenses including $14.2M depreciation and amortization.

  • Working Capital Deficit

    As of June 30, 2026, working capital deficit was $33.3M with cash of $4.9M, though management states a Stanley Hills funding support agreement through August 28, 2027 alleviates going concern doubt.

  • Ineffective Disclosure Controls

    CEO and CFO concluded that disclosure controls and procedures were not effective as of June 30, 2026, continuing a prior material weakness.

  • New $15M Convertible Financing

    On July 20, 2026, VisionWave closed a $15M convertible debenture financing with YA II PN, Ltd., with a fixed conversion price of $5.00 per share and warrants for 1.8M shares at $5.00.


Analysis · VWAV · Technology

The Q3 10-Q from VisionWave shows a net loss of $45.8M for the nine months ended June 30, 2026, alongside a working capital deficit of $33.3M and cash of just $4.9M. Management points to a funding support agreement with Stanley Hills through August 2027 as the reason going concern doubt is alleviated, yet the company's disclosure controls remain ineffective. Subsequent events include a $15M convertible debenture financing with YA II PN, Ltd. and a conversion of $1.25M of notes at $1.00 per share, which adds significant dilution risk.

How filings like this one have moved

In the 30 days to Nov 2, 2026, 40.4% of the 1069 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VWAV was trading at $1.24 on NASDAQ in the Technology sector, with a market capitalization of approximately $34.2M. The 52-week trading range was $1.03 to $15.80. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VWAV - Latest Insights

VWAV
Oct 14, 2026, 5:26 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $4.08
Real-time Price: $2.19 info
Change: -$1.89 (-46%) info
Market Cap: $7.124M info
VWAV
Oct 13, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.39
Real-time Price: $2.19 info
Change: -$2.20 (-50%) info
Market Cap: $7.124M info
VWAV
Oct 01, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.32
Real-time Price: $2.19 info
Change: -$2.13 (-49%) info
Market Cap: $7.124M info
VWAV
Sep 24, 2026, 8:45 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $2.19 info
Change: -$3.11 (-59%) info
Market Cap: $7.124M info
VWAV
Sep 24, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $2.19 info
Change: -$3.11 (-59%) info
Market Cap: $7.124M info